{"id":"https://openalex.org/W2765855720","doi":"https://doi.org/10.1016/j.jalz.2017.06.123","title":"[P1\u2013056]: POPULATION PHARMACOKINETIC\u2010PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE\u20109 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS","display_name":"[P1\u2013056]: POPULATION PHARMACOKINETIC\u2010PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE\u20109 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2765855720","doi":"https://doi.org/10.1016/j.jalz.2017.06.123","mag":"2765855720"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2017.06.123","doi":"https://doi.org/10.1016/j.jalz.2017.06.123","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2017.06.123","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010189987","display_name":"Edgar L. Schuck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edgar L. Schuck","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113065527","display_name":"Robert Y. K. Lai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Y.K. Lai","raw_affiliation_strings":["Eisai Ltd., Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd., Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113714866","display_name":"Jagadeesh Aluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jagadeesh Aluri","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022334220","display_name":"Ziad Hussein","orcid":"https://orcid.org/0000-0002-9129-853X","observed_orcids":["https://orcid.org/0000-0002-9129-853X"]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ziad Hussein","raw_affiliation_strings":["Eisai Ltd., Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd., Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045365891","display_name":"Mitsuhiro Ino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuhiro Ino","raw_affiliation_strings":["Eisai Co. Ltd., Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co. Ltd., Tsukuba, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108647151","display_name":"Sadaharu Kotani","orcid":"https://orcid.org/0009-0001-5392-1167","observed_orcids":["https://orcid.org/0009-0001-5392-1167"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sadaharu Kotani","raw_affiliation_strings":["Eisai Co. Ltd., Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co. Ltd., Tsukuba, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113852041","display_name":"Min\u2010Kun Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min\u2010Kun Chang","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002542527","display_name":"Ishani Savant Landry","orcid":"https://orcid.org/0000-0002-4865-4754","observed_orcids":["https://orcid.org/0000-0002-4865-4754"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ishani Savant\u2010Landry","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028315849","display_name":"Johan Luthman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Johan Luthman","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028315849"],"corresponding_institution_ids":["https://openalex.org/I4210151718"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"13","issue":"7S_Part_5","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.7310000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.7310000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.20679999887943268,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8680388927459717},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7710511684417725},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6247772574424744},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6243404746055603},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.46743646264076233},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.46594464778900146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44967252016067505},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06736698746681213},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2017.06.123","doi":"https://doi.org/10.1016/j.jalz.2017.06.123","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2017.06.123","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2765994429","https://openalex.org/W4282946702","https://openalex.org/W2896422012","https://openalex.org/W2897249465","https://openalex.org/W2766188293","https://openalex.org/W3036039687","https://openalex.org/W2182639219","https://openalex.org/W4407678636","https://openalex.org/W7131821526","https://openalex.org/W2579907512"],"abstract_inverted_index":{"To":[0],"develop":[1],"a":[2,9,39,89,139,185,241],"population":[3,56,90],"pharmacokinetic/pharmacodynamic":[4],"(PPK/PD)":[5,92],"model":[6,93,142,189,226,248,255],"for":[7,249,262],"E2027,":[8,37],"selective":[10],"PDE9":[11],"inhibitor,":[12],"following":[13,127],"single":[14,45],"ascending":[15,46,217],"oral":[16,129],"doses":[17,261],"in":[18,30,51,85,98,122],"healthy":[19],"volunteers":[20],"(HV),":[21],"which":[22],"will":[23],"be":[24],"used":[25,84,113],"to":[26,55,94,114],"drive":[27],"dose":[28,72,166,218],"selection":[29,257],"subsequent":[31,86],"studies.":[32],"Plasma":[33],"concentration-time":[34],"data":[35,214],"of":[36,66,79,88,133,173,194,199,258,264],"from":[38,125,179,215,244],"4-part":[40],"randomized,":[41],"double":[42],"blind,":[43],"placebo-controlled,":[44],"dose,":[47],"Phase":[48],"1":[49],"study":[50],"HV,":[52],"were":[53,75,83,112,156,181],"subjected":[54],"PK":[57,74,108,132,172,211],"analysis":[58],"by":[59,138,184],"nonlinear":[60],"mixed":[61],"effect":[62],"modeling.":[63],"The":[64,106,131],"effects":[65],"various":[67],"baseline,":[68],"demographic":[69],"characteristics":[70],"and":[71,109,119,151,165,197,204,212],"on":[73,190],"evaluated.":[76],"Post-hoc":[77],"estimates":[78],"final":[80,107],"PPK":[81,203],"parameters":[82,155],"development":[87],"PK/PD":[91],"describe":[95],"the":[96,171,202,222],"changes":[97,178],"cerebrospinal":[99],"fluid":[100],"(CSF)":[101],"cGMP":[102,124,177,239,274],"concentrations":[103],"over":[104],"time.":[105],"PPK/PD":[110,205,225,247],"models":[111,206],"predict":[115],"E2027":[116,134,230,250],"steady-state":[117],"exposures":[118],"percent":[120],"increase":[121,243],"CSF":[123,176,273],"baseline":[126,180],"multiple":[128,216],"doses.":[130],"was":[135,251],"best":[136,182],"described":[137,183],"2":[140],"compartment":[141],"with":[143,147,158,192,210],"two":[144],"input":[145],"functions":[146],"five":[148],"transit":[149],"compartments,":[150],"first-order":[152],"elimination.":[153],"All":[154],"estimated":[157],"good":[159],"precision":[160],"(CV%":[161],"<10%).":[162],"Weight,":[163],"gender,":[164],"(>200":[167],"mg)":[168],"significantly":[169],"affected":[170],"E2027.":[174],"Percent":[175],"sigmoidal":[186],"inhibitory":[187],"Emax":[188],"kout,":[191],"IC50":[193],"118":[195],"ng/mL,":[196],"Imax":[198],"0.813.":[200],"Although,":[201],"are":[207],"being":[208],"updated":[209],"PD":[213],"studies,":[219,266],"simulations":[220],"using":[221],"currently":[223],"developed":[224],"suggest":[227],"that":[228,270],"once-daily":[229],"dosed":[231],"at,":[232],"or":[233],"above":[234],"100":[235],"mg":[236],"should":[237],"maintain":[238],"at":[240],"3-fold":[242],"baseline.":[245],"A":[246],"successfully":[252],"developed.":[253],"This":[254],"supports":[256],"once":[259],"daily":[260],"proof":[263],"concept":[265],"demonstrating":[267],"target":[268],"engagement":[269],"provides":[271],"adequate":[272],"level":[275],"elevations.":[276]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-11-10T00:00:00"}